earlier use of immune checkpoint inhibitors to adjuvant and non muscle invasive bladder cancer
Published 1 year ago • 228 plays • Length 10:44Download video MP4
Download video MP3
Similar videos
-
15:22
neoadjuvant immune checkpoint inhibition for muscle invasive bladder cancer
-
21:37
non-muscle invasive bladder cancer: guidelines-based approach
-
19:21
immunotherapy for muscle invasive bladder cancer
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
19:16
checkpoint inhibitors for nmibc
-
19:16
diagnosis & treatment of non-muscle invasive bladder cancer: aua/suo guidelines
-
1:41:25
management of non muscle invasive bladder cancer webcast (2021)
-
2:01
immune checkpoint inhibitors in urothelial bladder cancer
-
14:18
barriers to clinical trials for non-muscle invasive bladder cancer
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
1:01:39
3.30.2020 urology covid didactics - non-muscle invasive bladder cancer
-
20:29
neoadjuvant and adjuvant chemotherapy in bladder cancer
-
24:15
bladder cancer and immunotherapy
-
23:44
a review of aua/suo/astro guidelines for muscle invasive bladder cancer (mibc)
-
11:40
point-counterpoint: muscle invasive bladder cancer–cystectomy perspective
-
11:15
beyond checkpoint inhibition: new therapeutic approaches to bladder cancer
-
51:51
beyond bcg in non-muscle invasive bladder cancer